GZMB and polyneuropathy: Given the inability to identify any other known disease genes that might explain the unusual phenotypic features (i.e. polyneuropathy, cognitive deficiency) associated with known bona fideAGPAT2-related CGL1 clinical manifestations in this patient, we suggest a potential phenotypic expansion.